ISOLATION, CHARACTERIZATION AND ANTI-TUMOUR PROPERTIES OF NOVEL CHIRAL ORGANOTIN (IV) COMPLEXES OF PHENANTHROLINES
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
ISOLATION, CHARACTERIZATION AND ANTI-TUMOUR PROPERTIES OF NOVEL CHIRAL ORGANOTIN (IV) COMPLEXES OF PHENANTHROLINES ; volume:10 ; number:2-3 ; year:2004 ; pages:181-186
Heterocyclic communications ; 10, Heft 2-3 (2004), 181-186
- Creator
-
Chaudhary,, Ashu
Phor,, Anita
Gaur,, Shweta
Singh,, R.V.
- DOI
-
10.1515/HC.2004.10.2-3.181
- URN
-
urn:nbn:de:101:1-2501130351134.274990307071
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chaudhary,, Ashu
- Phor,, Anita
- Gaur,, Shweta
- Singh,, R.V.
Other Objects (12)
Acid affairs in anti-tumour immunity
Ruthenacarborane complexes as building blocks for the design of novel anti-tumour agents
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
Acid affairs in anti-tumour immunity
Ruthenacarborane complexes as building blocks for the design of novel anti-tumour agents
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
Acid affairs in anti-tumour immunity
Ruthenacarborane complexes as building blocks for the design of novel anti-tumour agents
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity